Raleigh pharma raises $5M as phase 3 study begins By: Triangle Business Journal via Business Journals March 16, 2023 at 07:44 AM EDT A Raleigh pharmaceutical company is raising money as it moves its lead drug into a late-stage study. Read More >> Related Stocks: Harbor Disruptive Innovation ETF
